Pnd141 - Characteristics and Management of Migraine Patients Who Have Failed Prior Preventive Treatment in Portugal

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2106
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pnd67 - Are New Preventive Migraine Drugs Cost-Effective for Patients With Chronic and Episodic Migraine for Whom Other Preventive Medications Had Failed?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Treatment of Multiple Myeloma Patients Who Have Received at Least One Prior Therapy

European Oncology and Haematology
OncologyHematology
2007English

096 Assessment of the Efficacy of Erenumab During the Open-Label Treatment (13–24 Weeks) of Subjects With Episodic Migraine Who Failed 2–4 Prior Preventive Treatments: Results of the LIBERTY Study

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2019English

Fremanezumab for Preventive Treatment of Migraine

Neurology
Neurology
2018English

Olokizumab Treatment of Both Western and Asian Patients With Rheumatoid Arthritis Who Have Failed Anti-TNF Treatment Results in Sustained Improvements in Patient-Reported Outcomes

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Pnd6 - Characterization of Preventive Treatment in Episodic and Chronic Migraine Patients Managed by General Practitioners in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Personalized Peptide Vaccination for Cervical Cancer Patients Who Have Received Prior Platinum-Based Chemotherapy

Cancer Science
Cancer ResearchMedicineOncology
2015English

Four Million Patients Who Failed to Attend

BMJ
1984English

Points: Four Million Patients Who Failed to Attend

BMJ
1984English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy